VBI Vaccines
VBIV
#10524
Rank
NZ$3.25 M
Marketcap
NZ$0.11
Share price
0.00%
Change (1 day)
-89.56%
Change (1 year)

Market capitalization of VBI Vaccines (VBIV)

Last known market cap: NZ$3.25 Million

As of December 2025 VBI Vaccines has a market cap of NZ$3.25 Million. This makes VBI Vaccines the world's 10524th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of VBI Vaccines from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$3.25 M-2.12%
2024NZ$3.32 M-84.91%
2023NZ$22 M-86.17%
2022NZ$0.15 B-81.95%
2021NZ$0.88 B-4.45%
2020NZ$0.92 B152.57%
2019NZ$0.36 B57.31%
2018NZ$0.23 B-39.47%
2017NZ$0.38 B135.62%
2016NZ$0.16 B17.82%
2015NZ$0.13 B116.46%
2014NZ$63.83 M14.13%
2013NZ$55.93 M-45.7%
2012NZ$0.10 B-62.56%
2011NZ$0.27 B21.13%
2010NZ$0.22 B573.51%
2009NZ$33.72 M951.7%
2008NZ$3.2 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
NZ$36.28 M 1,016.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ$1.08 B 33,244.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
NZ$25.8 M 693.84%๐Ÿ‡บ๐Ÿ‡ธ USA